GlobeNewsWire
01 Sept 2026, 20:50 UTC · 7w ago
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in PROCEPT BioRobotics Corporation of Class Action Lawsuit and Upcoming Deadlines – PRCT
Impact · against what's priced in
The article provides no new catalyst for PRCT, as the legal claims and inventory failures described are already reflected in the current valuation. PLAB and AIRS are mentioned only as subjects of legal scrutiny, representing standard regulatory risks for these entities.
- PRCT+0.00
Already priced in
- The price assumes
The full severity of the class action lawsuit and the 10,000+ excess handpiece inventory glut





